These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 15970984

  • 1. [Use of positron-emission tomography with F18-fluorodeoxyglucose for the assessment of lung lesions suspicious of malignancy].
    Jofré MJ, Massardo T, González P, Canessa J, Sierralta P, Humeres P, Galaz R, Valdebenito R.
    Rev Med Chil; 2005 May; 133(5):583-92. PubMed ID: 15970984
    [Abstract] [Full Text] [Related]

  • 2. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
    Daniels CE, Lowe VJ, Aubry MC, Allen MS, Jett JR.
    Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584
    [Abstract] [Full Text] [Related]

  • 3. [Positron-emission tomography in the evaluation of lung cancer].
    Torres García AJ, Carreras Delgado JL.
    Arch Bronconeumol; 1997 Dec; 33(11):553-5. PubMed ID: 9508470
    [No Abstract] [Full Text] [Related]

  • 4. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
    Bryant AS, Cerfolio RJ.
    Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
    [Abstract] [Full Text] [Related]

  • 5. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [Abstract] [Full Text] [Related]

  • 6. Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules.
    Maiga AW, Deppen SA, Mercaldo SF, Blume JD, Montgomery C, Vaszar LT, Williamson C, Isbell JM, Rickman OB, Pinkerman R, Lambright ES, Nesbitt JC, Grogan EL.
    JAMA Surg; 2018 Apr 01; 153(4):329-334. PubMed ID: 29117314
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
    Lee ST, Berlangieri SU, Poon AM, Mitchell P, Pathmaraj K, Tabone K, Byrne AJ, O'Keefe GJ, Knight SR, Clarke CP, Scott AM.
    Intern Med J; 2007 Nov 01; 37(11):753-9. PubMed ID: 17517082
    [Abstract] [Full Text] [Related]

  • 8. 18Fluorodeoxyglucose positron emission tomography, a standard diagnostic tool in lung cancer.
    Giaccone G.
    J Natl Cancer Inst; 2007 Dec 05; 99(23):1741-3. PubMed ID: 18042929
    [No Abstract] [Full Text] [Related]

  • 9. Respiratory-gated imaging in metabolic evaluation of small solitary pulmonary nodules: 18F-FDG PET/CT and correlation with histology.
    Farid K, Poullias X, Alifano M, Regnard JF, Servois V, Caillat-Vigneron N, Petras S.
    Nucl Med Commun; 2015 Jul 05; 36(7):722-7. PubMed ID: 25793929
    [Abstract] [Full Text] [Related]

  • 10. 18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review.
    Ung YC, Maziak DE, Vanderveen JA, Smith CA, Gulenchyn K, Lacchetti C, Evans WK, Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care.
    J Natl Cancer Inst; 2007 Dec 05; 99(23):1753-67. PubMed ID: 18042932
    [Abstract] [Full Text] [Related]

  • 11. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
    Kim SC, Machac J, Krynyckyi BR, Knesaurek K, Krellenstein D, Schultz B, Gribetz A, DePalo L, Teirstein A, Kim CK.
    Ann Nucl Med; 2008 Apr 05; 22(3):165-70. PubMed ID: 18498030
    [Abstract] [Full Text] [Related]

  • 12. 18-fluorine fluorodeoxyglucose positron emission tomography with computerized tomography versus computerized tomography alone for the management of solitary lung nodules with diameters inferior to 1.5 cm.
    Divisi D, Di Tommaso S, Di Leonardo G, Brianzoni E, De Vico A, Crisci R.
    Thorac Cardiovasc Surg; 2010 Oct 05; 58(7):422-6. PubMed ID: 20922626
    [Abstract] [Full Text] [Related]

  • 13. [Value of [18F]-FDG-PET/CT as a predictor of cancer in solitary pulmonary nodule].
    Martins Rde C, Almeida SA, Siciliano AA, Landesmann MC, Silva FB, Franco CA, Fonseca LM.
    J Bras Pneumol; 2008 Jul 05; 34(7):473-80. PubMed ID: 18695792
    [Abstract] [Full Text] [Related]

  • 14. Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
    Aquino SL, Fischman AJ.
    Chest; 2004 Sep 05; 126(3):755-60. PubMed ID: 15364753
    [Abstract] [Full Text] [Related]

  • 15. Impact of whole-body ¹⁸F-fluorodeoxyglucose positron emission tomography on therapeutic management of non-small cell lung cancer.
    Heo EY, Yang SC, Yoo CG, Han SK, Shim YS, Kim YW.
    Respirology; 2010 Nov 05; 15(8):1174-8. PubMed ID: 20573060
    [Abstract] [Full Text] [Related]

  • 16. [Proposal for a diagnostic algorithm for the use of (18)F-FDG-PET in lung cancer].
    Borrego-Dorado I, Vázquez-Albertino R.
    Rev Esp Med Nucl; 2009 Nov 05; 28(3):167-72. PubMed ID: 19558959
    [No Abstract] [Full Text] [Related]

  • 17. Imaging in lung cancer: positron emission tomography scan.
    Vansteenkiste JF.
    Eur Respir J Suppl; 2002 Feb 05; 35():49s-60s. PubMed ID: 12064681
    [Abstract] [Full Text] [Related]

  • 18. Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer.
    Lardinois D, Weder W, Roudas M, von Schulthess GK, Tutic M, Moch H, Stahel RA, Steinert HC.
    J Clin Oncol; 2005 Oct 01; 23(28):6846-53. PubMed ID: 16192576
    [Abstract] [Full Text] [Related]

  • 19. Fluorodeoxyglucose-PET in characterizing solitary pulmonary nodules, assessing pleural diseases, and the initial staging, restaging, therapy planning, and monitoring response of lung cancer.
    Mavi A, Lakhani P, Zhuang H, Gupta NC, Alavi A.
    Radiol Clin North Am; 2005 Jan 01; 43(1):1-21, ix. PubMed ID: 15693644
    [Abstract] [Full Text] [Related]

  • 20. Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan.
    Dewan NA, Shehan CJ, Reeb SD, Gobar LS, Scott WJ, Ryschon K.
    Chest; 1997 Aug 01; 112(2):416-22. PubMed ID: 9266877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.